dioscin has been researched along with Colorectal Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Gong, G; Li, M; Li, T; Li, W; Liu, H; Liu, W; Yu, X; Zhou, L; Zuo, H | 1 |
1 other study(ies) available for dioscin and Colorectal Cancer
| Article | Year |
|---|---|
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Topics: Aerobiosis; Animals; Antigens, CD; Cadherins; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Diosgenin; Glycolysis; Humans; Mice, Nude; Proteolysis; S-Phase Kinase-Associated Proteins; Ubiquitination; Xenograft Model Antitumor Assays | 2020 |